Question 1

Is Verzenio tablet considered chemotherapy?

Accepted Answer

No, Verzenio is not classified as chemotherapy. It is a targeted therapy that works differently from traditional chemotherapy. While chemotherapy targets and kills rapidly dividing cells, including cancer cells, Verzenio specifically inhibits certain enzymes known as cyclin-dependent kinases (CDKs). This action helps to slow down the uncontrolled growth of cancer cells without directly killing them, making it a more targeted approach to cancer treatment.

Question 2

Is Verzenio considered immunotherapy?

Accepted Answer

No, Verzenio is not an immunotherapy; it is categorized as a targeted therapy. Unlike immunotherapy, which enhances the body’s immune system to detect and destroy cancer cells, Verzenio targets explicitly and inhibits specific proteins involved in cell growth, namely cyclin-dependent kinases (CDKs). This action helps slow cancer cell proliferation by engaging the immune system.

Question 3

How long is treatment with Verzenio typically required?

Accepted Answer

The duration of treatment with Verzenio depends on the stage of breast cancer being treated. For early-stage breast cancer, the usual course is about two years, although this may vary if the medication is not well tolerated or if the cancer recurs. In cases of advanced or metastatic breast cancer, treatment is often extended and continues until the medication is no longer tolerated or the tumor progresses. The duration is tailored to each patient’s situation, and the oncology team makes decisions. It is important not to discontinue Verzenio without consulting your oncologist.

Question 4

Can Verzenio cause weight gain?

Accepted Answer

Clinical studies involving Verzenio (abemaciclib) did not commonly report weight gain as a side effect. In research examining the impact of Verzenio combined with endocrine therapy for breast cancer, most participants did not experience significant changes in weight after 18 months of treatment. In fact, weight loss was more frequently observed than weight gain. If you have any concerns about weight changes while taking Verzenio, it’s important to discuss them with your oncology care team.